Analogic sells Cedara shares

Cedara Software Corp. announced that Analogic Corp. sold the 4,580,461 shares it held in Cedara, representing approximately 14.6 percent of the company's outstanding shares.
   
Analogic gained net proceeds of over $50 million from its investment in Cedara.
   
In September 2001, Analogic made a $7.5 million investment in Cedara in order to secure access to Cedara's medical imaging software.
   
Cedara recently inked a long-term deal to allow Analogic and its subsidiaries to use its software, and the two companies' sales organizations pledged to promote each other's products.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.